Entering text into the input field will update the search result below

FDA issues draft guidance on non-binding feedback on inspections

  • The FDA has issued draft guidance for medical device makers on how to request nonbinding feedback on certain kinds of Form 483 deficiencies noted during on-site inspections. The objective is to enable them address the issues in a more timely and consistent fashion. Previously, companies could only request feedback on their planned corrective actions.
  • A request for nonbinding feedback will be required to show how one or more observations meet statutory criteria, involve a public health priority, implicate systemic or major actions or relate to emerging safety issues. The agency will respond with 45 calendar days after receiving the request.
  • Selected tickers: ISRG, MDT, BSX, SYK, ZBH, SNN, RMD, TNDM, PODD, DXCM, BAX, ABT, EW

Recommended For You

Related Stocks

SymbolLast Price% Chg
ISRG--
Intuitive Surgical, Inc.
MDT--
Medtronic plc
BSX--
Boston Scientific Corporation
SYK--
Stryker Corporation
ZBH--
Zimmer Biomet Holdings, Inc.